Poop pills tested to calm chemo gut woes in cancer patients
NCT ID NCT07319364
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether fecal microbiota transplantation (FMT) – taking donor gut bacteria in capsules – can prevent or reduce gastrointestinal symptoms like nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy. It involves 90 adults with advanced (Stage IV) gastrointestinal cancers who are already on treatment. Researchers will track symptom changes after FMT given before cycles 4, 6, and 8 of their cancer therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplantation (FMT) capsules
- What this could lead to
- If it works, this could offer a way to reduce nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy in people with advanced gastrointestinal cancers.
- What could go wrong
- This is a small, early-phase (Phase 1) observational study, so results are preliminary. FMT may not work for everyone and carries risks like infection or digestive discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTINEOPLASTIC AGENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITINGZhejiang, Hangzhou, 310009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug cocktail shrink stomach tumors before surgery?
- Can we predict who will survive a bowel surgery leak?
- Can a new nucleotide analogue boost cancer treatment?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can 3D motion capture reveal hidden breathing problems after esophageal cancer surgery?
- Rearranging the treatment timeline: could a new sequence of chemo and radiation spare rectal cancer patients from major surgery?